Kiyoshi Yoshimura

Showa University — Japan

Medicine · Health Sciences

34h-index3.5kcitations211works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(62), Immunotherapy and Immune Responses(52), Immune Cell Function and Interaction(44), CAR-T cell therapy research(25), Pancreatic and Hepatic Oncology Research(24)

Publications211 total

Genomic Characterisation of Red Sea Bream Iridovirus (RSIV) Samples Collected in Japan in 2024 Revealed Genotype II and the First Detection of the Intermediate Type in Japan
Journal of Fish Diseases·2025
Microfluidic droplet cultivation preserves microalgae diversity in screening systems
Scientific Reports·2025Open Access
Vinegar intake in patients undergoing immune checkpoint inhibitor therapy: food frequency questionnaire study
Frontiers in Immunology·2025Open Access
Eosinophils and the Efficacy of Immune Checkpoint Inhibitors Across Multiple Cancers: A Retrospective Study
Biomedicines·2025Open Access
1324 Innovative phase II clinical trial of gut microbiota targeting therapeutics to overcome acquired resistance to immune checkpoint inhibitors in solid tumors
2025Open Access
Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression
Frontiers in Immunology·2025· 2 citedOpen Access
Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity
Cancer Immunology Immunotherapy·2025· 4 citedOpen Access
Plasma WFDC2 (HE4) as a Predictive Biomarker for Clinical Outcomes in Cancer Patients Receiving Anti-PD-1 Therapy: A Pilot Study
Cancers·2025Open Access
Elevated plasma levels of WAP four-disulfide core domain 2 as a potential prognostic biomarker for various cancers
Frontiers in Oncology·2025Open Access
Combination therapy with levofloxacin and the probiotic <i>Clostridium butyricum</i><scp>MIYAIRI</scp> 588 enhances immune checkpoint inhibitor efficacy
International Journal of Cancer·2025· 4 cited
Veillonella and Streptococcus are associated with aging of the gut microbiota and affect the efficacy of immune checkpoint inhibitors
Frontiers in Immunology·2025· 3 citedOpen Access
Intestinal and esophageal microbiota in esophageal cancer development and treatment
Gut Microbes·2025· 7 citedOpen Access
Combination therapy with cetirizine and anti-PD-1 antibody suppresses colitis-induced colon tumor formation in mice
European Journal of Pharmacology·2025· 1 cited
Efficacy of Esophagectomy Following Neoadjuvant Chemotherapy for Esophageal Neuroendocrine Carcinoma
Anticancer Research·2025· 2 citedOpen Access
Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8+ T cells as a predictor of clinical benefit
Discover Oncology·2025· 1 citedOpen Access
Evaluation of patient immunocompetence for immune checkpoint inhibitor therapy using the psoas muscle index: a retrospective cohort study
Frontiers in Oncology·2025Open Access
Association between the <i>ABCC11</i> gene polymorphism-determined earwax properties and external auditory canal microbiota in healthy adults
Microbiology Spectrum·2025· 2 citedOpen Access
Implications of Nurse-led Screening for COVID-19 in Patients Receiving Cancer Drug Therapy
Annals of Cancer Research and Therapy·2025Open Access
Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors
Cancer Genomics & Proteomics·2024Open Access
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice
Biomedicine & Pharmacotherapy·2024· 6 citedOpen Access
page 1 of 11Next →

Frequent Co-authors

Shoichi Hazama(19), Masaaki Oka(16), Satoshi Wada(13), Shigefumi Yoshino(13), Richard D. Schulick(10), Ryouichi Tsunedomi(10), Drew M. Pardoll(9), Yoshitaro Shindo(9), Hiroto Matsui(9), Kazuyuki Hamada(9), Ryotaro Ohkuma(9), Yutaro Kubota(9), Yuya Hirasawa(9), Hirotsugu Ariizumi(9), Takuya Tsunoda(9), Nobuaki Suzuki(8), Midori Shida(8), Tomoyuki Ishiguro(8), Junji Tsurutani(8), Shinichi Kobayashi(8)